Lendacin

Quick links to important sections

Lendacin

Selected form

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lendacin

Quick Facts

Property Description
Active ingredient Ceftriaxone
Form Sterile powder for solution for injection or infusion
Pharmacological class Third-generation cephalosporin antibiotic
Common use Treatment of serious bacterial infections
Origin Semisynthetic

What is Lendacin? Definition and Classification

Lendacin is a prescription-only, semisynthetic antibiotic medication that belongs to the third-generation cephalosporin class. Its sole active ingredient is Ceftriaxone (INN), a compound essential for combating susceptible bacterial infections. This drug entity is classified as a third-generation cephalosporin, a designation reflecting its enhanced efficacy and stability profile compared to older agents. The drug's semisynthetic origin signifies that it is chemically modified from a natural precursor, a process utilized to optimize its antimicrobial characteristics. Its efficacy is clinically recognized for managing serious systemic infections, firmly establishing Lendacin's fundamental role as a critical anti-infective agent.


Composition, Form, and General Therapeutic Purpose

Lendacin is supplied as a sterile powder for solution for injection or infusion, intended for parenteral use, and its general purpose is the elimination of bacterial infections. The product contains the stable salt form, Ceftriaxone sodium. The form mandates parenteral administration (via intramuscular or intravenous administration), which ensures the necessary concentration of the active ingredient reaches the bloodstream quickly. As a bactericidal agent, Ceftriaxone works by inhibiting cell wall synthesis in bacteria, thus actively killing the microorganisms. Ceftriaxone is included on the Model List of Essential Medicines, confirming its critical role in managing significant health concerns worldwide. This robust broad-spectrum mechanism provides a decisive therapeutic defense against a wide array of susceptible and often serious bacterial infections.

What side effects are possible with Lendacin?

Possible Side Effects and Safety Information

The safety profile of Lendacin (Ceftriaxone) is officially characterized by specific adverse reaction classifications and regulatory restrictions, as documented by governmental health authorities.

Official Adverse Reaction Classifications

Adverse reactions are formally grouped into System-Organ Classes (SOC), with incidence determined through clinical trials and postmarketing surveillance. The most common effects involve Gastrointestinal Disorders (such as diarrhea) and Blood and Lymphatic System Disorders (including eosinophilia and leukopenia).

Reactions classified as uncommon include headache, dizziness, nausea, vomiting, rash, and phlebitis at the injection site. Rare documented effects encompass more serious conditions such as pseudomembranous colitis, severe neurological reactions (including encephalopathy), and anaphylactic shock.

Critical Safety Constraints

The official labeling highlights specific restrictions, particularly concerning the interaction with calcium. Lendacin is contraindicated for simultaneous intravenous administration with calcium-containing solutions in patients of all ages, due to the risk of potentially fatal precipitation.

Furthermore, its use is contraindicated in hyperbilirubinemic neonates and pre-term neonates due to the theoretical risk of kernicterus. Patients with known hypersensitivity to the cephalosporin class must also not use this medicine. The final safety profile is structured to inform on both common expected effects and critical, rare safety limitations.

Overdose and Emergency Response

Overexposure to Lendacin (Ceftriaxone) is managed as a medical emergency, with official regulatory documents detailing the specific clinical manifestations that may occur. Documented adverse reactions associated with high concentrations or unadjusted dosing are primarily neurological, including encephalopathy (e.g., disturbance of consciousness, confusion, somnolence), myoclonus, and seizures, including the severe outcome of non-convulsive status epilepticus. Gastrointestinal effects such as nausea, vomiting, and diarrhea have also been observed.

A critical risk documented by regulators is the formation of drug-calcium salt precipitates in the body. This is a dose-related toxicity that may lead to the development of biliary precipitates (pseudolithiasis) in the gallbladder or kidneys. This risk is specifically noted for infants and children and in patients with severe renal or combined hepatic impairment.

Mandatory Emergency Action

Regulatory guidance explicitly states that individuals who suspect overexposure must seek immediate medical attention. If severe, life-threatening signs are present—such as collapse, trouble breathing, seizures, or inability to be awakened—it is required to immediately call emergency services. Official management is symptomatic and supportive, focusing on the immediate discontinuation of the drug. Regulators confirm that no specific antidote is known, and the medicine is not efficiently removed by either hemodialysis or peritoneal dialysis.

Therapeutic Uses of Lendacin

What Lendacin Treats: Main Uses and Benefits

Lendacin is commonly used across conditions presenting with acute episodes. The treatment is relevant in conditions involving inflammatory or irritative processes, and conditions associated with acute or disruptive episodes. It is commonly used across conditions presenting with systemic or localized discomfort.

This medicine helps address symptom clusters that may become intense or disruptive, such as symptoms related to systemic imbalance (like high fever and chills) and symptoms that create noticeable physiological strain. It provides support that helps ease the overall symptom burden during these difficult acute episodes.

“Lendacin assists with maintaining functional stability during episodes of heightened discomfort.”

Quick Fact: Relief for Systemic Discomfort

Lendacin is relevant when supportive symptom management is appropriate. It contributes to improved comfort by supporting the patient during symptomatic periods marked by temporary physiological imbalance.

Eligibility and Restrictions for Use

Lendacin use is absolutely contraindicated for patients with a known hypersensitivity to ceftriaxone, any excipient, or to any other cephalosporin class antibiotic. The medicine is also strictly forbidden for certain neonates: those who are premature (up to 41 weeks postmenstrual age), those with hyperbilirubinemia, and any neonate requiring concurrent intravenous calcium-containing solutions due to the documented risk of ceftriaxone-calcium precipitation.

Eligibility remains conditional for several patient groups. Use during pregnancy (Category B) and while breastfeeding is restricted and requires caution, as the drug is excreted in human milk. Patients with combined severe hepatic and renal impairment have their use restricted, and typically should not exceed a specific low maximum daily amount. Older adults and patients with isolated renal or hepatic impairment are generally eligible for use without standard dosage adjustments for daily amounts up to two grams, as documented in regulatory guidelines.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documents define specific interaction patterns for Lendacin (Ceftriaxone), which center primarily on physical incompatibility and pharmacodynamic effects.

Contraindicated Combinations and Timing Rules

Intravenous solutions that contain calcium, such as Ringer's or TPN, are strictly contraindicated for co-administration with Lendacin in neonates (patients 28 days of age or younger). This prohibition is documented due to the risk of forming potentially fatal ceftriaxone-calcium salt precipitates. In all other patients, Lendacin and calcium-containing solutions must not be mixed or administered simultaneously, even via separate infusion lines; sequential administration is permitted only if the lines are thoroughly flushed.

Pharmacodynamic and Clearance Interactions

Co-administration with Warfarin and other Vitamin K antagonists is associated with documented alterations in prothrombin time, which increases the risk of bleeding. Furthermore, the combination with Aminoglycoside antibacterials carries a documented risk of increased nephrotoxicity.

The official label states that Probenecid, administered at high doses, may decrease the renal clearance of Lendacin, resulting in increased systemic drug exposure.

Physical Incompatibility

Lendacin is physically incompatible with and must not be mixed in the same intravenous solution with several other agents, including Vancomycin, Amsacrine, and Fluconazole.

Mechanism of Action

Lendacin (Ceftriaxone) functions as a bactericidal agent by disrupting the foundational mechanisms of bacterial cell survival. Its action is centered on the irreversible inactivation of bacterial enzymes.

Targeted Blockade of Bacterial Cell Wall Synthesis

Ceftriaxone acts by binding irreversibly to Penicillin-Binding Proteins (PBPs), bacterial enzymes essential for building the cell wall's rigid peptidoglycan structure. The drug's molecular structure acylates the enzyme, halting the necessary cross-linking step and triggering the subsequent loss of structural integrity. This mechanism is concentration-dependent, enabled by the drug's confirmed penetration into compartments like the Cerebrospinal Fluid (CSF) to engage its targets.

The Mechanistic Cascade: Lysis and Pathogen Cellular Destruction

The PBP blockade leads to the formation of a structurally weak cell wall, which subsequently yields to internal osmotic pressure and the activation of bacterial autolytic enzymes. This cascade results in cell lysis (bursting), which is the physical mechanism responsible for the drug's core physiological effect of cellular destruction of susceptible pathogens.

Dosage and Administration Information

How Lendacin is Used: Official Dosing and Administration

Lendacin (Ceftriaxone) is a prescription antibiotic whose usage is strictly confined to professional, supervised settings due to its method of administration. All instructions for use, including dosing and preparation, follow the precise guidelines outlined by regulatory bodies.

Approved Administration Routes and Preparation

Lendacin is supplied as a sterile powder that must be reconstituted before use. It is administered via the parenteral route only:

  • Intravenous (IV) Use: Administered as a slow IV injection (over 2 to 4 minutes) or as an IV infusion (typically over 30 minutes). For reconstitution, a calcium-free solution (such as 0.9% saline) must be used.
  • Intramuscular (IM) Use: Injected deep into a large muscle. Reconstitution may be performed with 1% lidocaine solution, though official labeling recommends not exceeding 1 gram per single IM site.

Standard Dosing and Frequency

For most adult patients (≥ 50 kg), the general dosing range and frequency are standardized:

Regimen Component Standard Official Guideline
Typical Daily Dose 1 to 2 grams
Maximum Daily Dose 4 grams (for severe infections)
Dosing Frequency Once daily (every 24 hours)
Standard Duration 4 to 14 days (continues 48 to 72 hours after fever resolves)

Special Administration Conditions

Lendacin must not be mixed with, or administered simultaneously through the same IV line as, any calcium-containing solutions or products. Dosage adjustments are not typically required for standard doses in patients with isolated renal or hepatic impairment. However, official guidelines specify that patients with both severe renal and hepatic dysfunction should generally not exceed 2 grams per day.

Recent Clinical Evidence

Research evidence / Overview of studies for Lendacin (Ceftriaxone)


Evidence for Use in Severe Systemic and Central Nervous System Infections

Lendacin was studied for severe, life-threatening conditions, including bacterial meningitis and septicemia (bloodstream infections). The evidence base primarily consists of Randomized Controlled Trials (RCTs) and comparative studies, evaluating populations including adults, children, and neonates. Research examined confirming microbial eradication in the cerebrospinal fluid and monitoring mortality rates. Findings describe patterns related to achieving a clinical response. However, data are still emerging regarding the optimal defined time intervals for treatment for all types of bloodstream infections.


Evidence for Use in Respiratory and Organ Infections

Evidence for Community-Acquired Pneumonia (CAP) and complicated urinary tract infections (cUTI) includes numerous RCTs and systematic reviews. These studies evaluated hospitalized adults, focusing on outcomes linked to inflammatory states. Primary measures included clinical cure/response and microbiological eradication. Research is ongoing regarding dose schedules for critically ill patients with CAP, as their body's processing of the drug may be highly variable. In some observational studies related to complicated infections, findings were mixed regarding specific, complex scenarios, and monitoring patterns of resistance is necessary.


Evidence in Special Populations and Long-Term Studies

Specific research has been evaluated in patient groups where drug concentration can vary, including pediatric patients and those with kidney or liver conditions. These studies primarily focused on pharmacokinetic (PK) outcomes—how the body handles the medicine. Data show patterns related to differences in drug levels for neonates and critically ill adults. Sample sizes were modest in some of these specialized PK studies, meaning subgroup findings are uncertain regarding the need for altered dosing. Furthermore, while long-term follow-up was observed in some meningitis populations for up to one year, long-term effects are not fully established for all indications.

Key Studies & References

  1. Ceftriaxone versus other antibiotics for the treatment of bacterial meningitis

Frequently Asked Questions (FAQ)

Common questions about Lendacin (FAQ)

Q: Is Lendacin the same as (Name of a fictional similar drug)?

Lendacin is classified as a third-generation cephalosporin antibiotic. Official product labeling focuses on the drug's properties and intended uses, and does not typically include direct comparisons regarding the effectiveness or superiority of Lendacin versus other specific medications in the same therapeutic class.

Q: How quickly does Lendacin start to work?

Because Lendacin is administered directly into the muscle or bloodstream via injection or infusion, it is rapidly and completely absorbed. Studies show that peak concentrations of the medicine in the blood are reached shortly after administration.

Q: How long do the effects of Lendacin usually last?

Official information indicates that Lendacin is characterized by an exceptionally long elimination half-life. This means the time it takes for the concentration of the medicine to reduce by half in the body typically ranges from about 6 to 9 hours in most human subjects.

Q: Can Lendacin cause fatigue or drowsiness?

While the drug is not specifically classified to cause drowsiness, official lists of adverse reactions have documented effects such as unusual tiredness, weakness, dizziness, and headache. These documented effects may temporarily affect an individual’s ability to perform certain tasks.

Q: Are there any common foods or drinks to avoid while taking Lendacin?

According to the official product information, there are no specific restrictions listed for common foods or non-alcoholic drinks. This is because Lendacin is given by injection or infusion (parenteral administration), which bypasses the digestive system. The main drug and product restrictions relate to specific medications and calcium-containing solutions.

Q: Can Lendacin affect my sleep schedule?

Official drug labeling notes that nervous system side effects have been reported, including confusion and restlessness. While insomnia itself is not listed as a common effect, these reported nervous system effects could potentially impact normal sleep patterns.

Q: Are there any specific organs Lendacin might affect over time?

Regulatory warnings highlight specific organs and systems that require caution, especially with certain patient populations. Documented concerns include a risk of precipitates in the lungs and kidneys of neonates. Additionally, caution is advised for patients with pre-existing conditions affecting the gallbladder, pancreas, liver, and kidneys, as well as those with blood coagulation issues.

Q: How does Lendacin compare to other medicines in the same category?

Official drug labeling and regulatory documents provide factual information about Lendacin's purpose, safety, and mechanism of action. The documents do not typically include comparative statements regarding its efficacy or superiority against other antibiotics in the same category.

Q: Does Lendacin need to be taken with food?

Lendacin is a sterile powder that is administered solely through the parenteral route (injection or infusion). Since the medicine is delivered directly into the body, requirements regarding food intake for absorption are not relevant to its use.

Q: Is Lendacin known to cause weight gain or loss?

According to regulatory adverse reaction documentation, weight gain is not listed as a reported effect. However, unusual weight loss is documented as an effect of unknown or rare incidence.

Q: Is Lendacin safe to take if I have existing liver issues?

Dosage adjustments are generally not necessary for patients with isolated liver dysfunction when receiving standard doses. However, official guidelines specify restrictions regarding the use of this medicine for patients with combined significant kidney and liver impairment.

Q: Can Lendacin be taken with common over-the-counter pain relievers?

Official drug interaction checkers indicate that some common over-the-counter pain relievers, such as acetaminophen and ibuprofen, may have potentially minor or moderate interactions with Lendacin. Information on interactions with other products is best reviewed by a healthcare professional.

Q: Does Lendacin interact with herbal supplements?

Official regulatory documents focus primarily on interactions with prescription drugs and known physical incompatibilities. Information regarding potential interactions with specific herbal or dietary supplements is not typically detailed in the main regulatory labeling.

Q: What are the signs of a serious allergic reaction to Lendacin?

The official patient information lists several potential signs of a severe allergic reaction. These may include hives, swelling of the face, hands, or throat, and difficulty with breathing or chest tightness.

Q: How long after starting Lendacin can I expect improvement?

Patient information suggests that an individual’s condition may begin to show improvement during the first few days of the treatment course. Treatment duration, however, typically lasts for multiple days as determined by the healthcare provider.

Q: Is there a generic version of Lendacin available?

The active ingredient, Ceftriaxone, is approved with an Abbreviated New Drug Application (ANDA) status. This status confirms that a generic version of the medicine is available on the market.

Q: Can people with kidney problems take Lendacin?

For patients with isolated kidney dysfunction, dosage adjustments are generally not necessary when standard doses are administered. However, regulatory guidelines note that there are specific restrictions regarding the use of this medicine for patients with combined significant kidney and liver impairment.

Q: Can I drink alcohol moderately while on Lendacin?

The active ingredient in Lendacin is generally not associated with the severe adverse reactions seen with some other types of antibiotics. However, as with many medications, combining alcohol with it may increase the risk of experiencing side effects such as dizziness or stomach upset.

Q: Is Lendacin used for any conditions other than the main listed use?

Official labeling lists the specific serious bacterial infections for which the drug is indicated. These include conditions such as Lower Respiratory Tract Infections, Skin and Skin Structure Infections, Bacterial Meningitis, and Complicated Urinary Tract Infections.

Q: Does taking Lendacin require any routine blood tests?

Official monitoring guidelines describe that health professionals may utilize lab tests to check the effects of the drug. This monitoring may involve checking a Complete Blood Count (CBC) and Liver Function Tests (LFTs), particularly for patients receiving prolonged treatment courses or those taking certain interacting medications.

Q: Does Lendacin interact with common antidepressants?

Official interaction checkers indicate that some common antidepressants may interact with Lendacin. Caution concerning specific combinations, such as with medications like Duloxetine, is a matter for the prescribing healthcare team.

Q: Are there any restrictions on driving while taking Lendacin?

Official warnings do not contain specific prohibitions regarding the act of driving. However, side effects such as dizziness and headache are reported, which are known to temporarily affect a person’s ability to drive or operate machinery safely.

Q: Is Lendacin a controlled substance?

According to the DEA schedule and official labeling information, Lendacin is categorized as not a controlled medication.

Q: What is the difference between a side effect and an adverse reaction?

Both terms refer to undesirable effects, but they are often distinguished in medical documents based on their regulatory classification. This classification is typically determined by the effect's frequency, severity, and the method through which it was discovered (e.g., in clinical trials versus postmarketing surveillance).

Q: Is Lendacin commonly prescribed for children?

Official labeling confirms that Lendacin is indicated for use in children, including term neonates (from birth), for certain infections. Specific use conditions and strict contraindications apply to neonates.

Q: Can I take Lendacin if I have high blood pressure?

High blood pressure (hypertension) is not listed as a specific contraindication or a required caution in the official regulatory warnings for this medicine.

Q: Is Lendacin known to cause dry mouth?

Dry mouth is not explicitly listed as a common or uncommon adverse effect in the regulatory documentation. Related effects such as increased thirst are sometimes reported, but these are noted to occur with unknown or rare incidence.

Q: How do doctors monitor the effects of Lendacin?

Official monitoring guidelines describe that health professionals may utilize lab tests to check the effects of the drug. This monitoring may involve checking a Complete Blood Count (CBC) and Liver Function Tests (LFTs), especially for patients on prolonged courses.

Q: What is the shelf life of Lendacin?

The stability of the medicine is clearly documented by the manufacturer. The reconstituted solution is stable for 48 hours at room temperature or 10 days when refrigerated. The dry powder itself is required to be stored at a controlled room temperature to maintain product quality.

Q: Does Lendacin contain any common allergens like gluten or lactose?

Official regulatory documentation lists the excipients (inactive ingredients) with known effects, noting that the drug contains sodium. However, common allergens such as gluten or lactose are not listed in the official documentation of the ingredients.

How should Lendacin be stored and disposed of?

The storage and disposal of Lendacin (ceftriaxone) must adhere strictly to official regulatory requirements to maintain product quality and safety.

Item Storage Condition (Dry Powder) Stability (Reconstituted Solution)
Temperature Store at Controlled Room Temperature (15 C to 30 C). Stable for 48 hours at room temperature (25 C) or 10 days when refrigerated (5 C).
Protection Keep in the original container and protect from light. Protection from normal light is permitted.

All medications, including Ceftriaxone powder, must be kept out of the sight and reach of children. Unused or expired drug product, as well as related waste materials, must be handled and disposed of according to local regulations and must not be placed into household wastewater or general trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lendacin found in:

A-Z Index: